维普期刊资源整合服务平台（V6.5）

2130篇 您的检索式：期刊名="Marker"

选中清除导出查看参考文献查看引证文献引用追踪共107页首页上一页第1页下一页末页 /107 跳转

	题名	作者	年代	出处	被引量
1	Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer显示文摘	Chao-Jie Wang Zong-Guang Zhou Ling Wang Lie Yang Bin Zhou Jun Gu Hong-Ying Chen Xiao-Feng Sun	2009	Disease Markers2009，，1：	2
2	Clinical significance of inflammatory markers in polycystic ovary syndrome:their relationship to insulin resistance and body mass index显示文摘	Samy N Hashim M Sayed M	2009	Dis Markers2009，26，4：	1
3	predicting prostate biopsy outcome by findings at digital rectal examintion,transrectal ultrasonograply PSA,PSA density and free-to total PSA ratio in a popcilationbased screening setting显示文摘	Ciatto S Bonardi R Lombardi C	2001	Int Biol Markers2001，16，3：	1
4	Progression model tissue microarray (TMA) for the study of uterine carcinomas显示文摘	Arafa M Boniver J Delvenne P	2010	Dis Markers2010，28，5：	1
5	Gene cloning of CD147/HAb18G and study of its function in human hepatoma cells显示文摘	Chen ZN Mi L Xing JL	2001	J Tumor Marker Oncol2001，16，4：	1
6	Downregulation of MUC1 and MUC1/Y expression in breast cancer cell line by a traditional Chinese medicine KangLaiTe显示文摘	Zhang L X Li C H Lu YF	2003	J Tumor Marker Oncol2003，18，1：	1
7	p53 and HER2/neu expression in relation to chemotherapy response in patients with non-small cell lung cancer显示文摘	Fijolek J Wiatr E Rowinska-Zakrzewska E	2006	Int J Biol Markers2006，21，2：	1
8	The role of RASSF1A hypermethylation in cancer 显示文摘	Hesson LB Cooper WN Latif F	2007	Dis Markers2007，23，12：	1
9	The Wiskott-Aldrich syn- drome: The actin cytoskeleton and immune cell function 显示文摘	Blundell M P Worth A Bouma G	2010	Dis Markers2010，29，：	1
10	Are 90K/MAC-2BP serum levels correlated with poor prognosis in HCC patients? Preliminary results显示文摘	Iacovazzi PA Guerra V Elba S	2003	Int J Biol Markers2003，18，3：	1
11	Human papillomavirus gen- otype distribution in low-grade cervical lesions: compariosn by geo- graphic region and with cervical cancer 显示文摘	Lifford GM Rana RK Francesehi S	2005	Cancer Epidemiol Bio- markers Prey2005，14，5：	1
12	Fibronectin, plasminogen activator inhibitor type 1 ( PAl - 1 ) and uterine artery Doppler velocimetry as markers of preeclampsia 显示文摘	Bodova KB Biringer K Dokus K	2011	Dis Markers2011，30，4：	1
13	The role of RASSF1A methylation in cancer显示文摘	Heson LB Cooper WN Latif F	2007	Dis Markers2007，23，12：	1
14	Plasma oxidized low-density lipo- protein is an independent risk factor in young patients with coro- nary artery disease显示文摘	Huang Y Hu Y Mai W	2011	Dis Markers2011，31，5：	1
15	Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China显示文摘	Chen HC Cao YF Hu WX	2006	Dis Markers2006，22，3：	1
16	Explore the Contribution of Manage-ment Innovation to the Evolution of Dynamic Capa-bility显示文摘	GEBAUER H	2011	Industrial Markering Management2011，40，8：	1
17	Pre-treatment prediction of chemoresistance in second-line chemotherapy of ovarian carcinoma: value of serological tumor marker determination ( tet ranectin , YKL-40, CASA, CA 125)显示文摘	Gronlund Bl Hogdall EV Christensen IJ	2006	Int J Biol Markers2006，21，3：	1
18	Limited value of KAI1/CD82 protein expression as a prognosticmarker in human gastric cancer显示文摘	Maximilian Knoener Till Krech Florian Puls Ulrich Lehmann Hans Kreipe Matthias Christgen	2012	Disease Markers2012，，6：	1
19	Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 显示文摘	Sikora K Bedin C Vicentini C	2015	The International Joumal of Biological Markers2015，30，1：	1
20	Lipoprotein(a) : a promising marker for residual cardiovascular risk assessment 显示文摘	Cai A Li L Zhang Y	2013	Dis Markers2013，35，5：	1

返回顶部每页显示：

共107页首页上一页第1页下一页末页 /107 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示